Thermo Fisher Scientific, Inc. is debuting its recently launched innovative products, hosting educational presentations and showcasing live lab demos for customers working in laboratory technology, analysis, biotechnology, and environmental quality.

AMSBIO reports that its extensive range of FDA tissue microarrays reliably enhances tissue cross-reactivity (TCR) and other target validation studies.

Bruker Corporation (Nasdaq: BRKR) is showcasing some of its latest innovations at Analytica 2024.

Collaboration aims to grow clinical evidence supporting the use of bio-Rad’s ddPCR™ technology for molecular residual disease monitoring of patients across a range of solid tumor types.

HORIBA Instruments Inc., is proud to announce the launch of their dedicated product solutions to address the impacts of microplastics on the environment and life forms.

Sebastian Arevalo's appointment strategically positions RedShiftBio to capitalize on growing opportunities in the biophysical characterization and bioprocess analytics markets, leveraging a proven track record in driving sales growth.

Highly sensitive and multiplexed assay for the detection, discrimination, and quantification of key mutations in ESR1 gene for breast cancer, developed for bio-Rad’s QX600™ droplet digital™ PCR system.

Applied Biosystems TaqMan QSY2 probes enable multiplexing of research assays for up to 6 targets in a single qPCR reaction with industry-leading TaqMan performance.

Addressing the growing need for complete ICP-MS and ICP-OES workflow automation in the lab.

Designed for food safety labs analyzing these emerging compounds of interest, Restek’s new multicomponent mix meets all compounds listed by AOAC SMPR 2019.004 and Commission Recommendation (EU) 2022/495.